annual meeting program - American Society of Clinical Oncology

SATURDAY
Saturday, June 5, 2010
Brd. 41H Identification of DNA methylation changes in esophageal cancer before/after
chemoradiation therapy using a MCA-microarray and bisulfate
pyrosequencing. (Abstract #10550)
T. Tsuda, Y. Watanabe, M. Hirakawa, K. Hosoya, N. Izawa, H. Inaba,
N. Matsumoto, M. Toyota, F. Itoh
Brd. 42A Prediction of response to neoadjuvant therapy in breast cancer using plasma
and tumor proteomic analyses. (Abstract #10551)
C. Desauw, L. Hornez, J. Bonneterre, M. Baranzelli, M. Chauvet, E. Blot,
A. Hollebecque, C. Fournier, A. Leroy, J. Peyrat
Brd. 42B Value of quantitative DNA fingerprinting in classification of second breast
tumors and association with outcome. (Abstract #10552)
B. L. Schlechter, P. S. Larson, Q. Yang, R. Klett, K. Armstong, A. de las Morenas,
C. L. Rosenberg
Brd. 42C CpG-b oligodeoxynucleotides potently activate human NK cells and sensitize
chronic lymphocytic leukemia cells to NK cell-mediated killing. (Abstract
#10553)
V. Bachanova, X. Liang, A. S. Chan, A. J. Peterson, L. Y. Chen, P. T. Robertson,
A. Panoskaltsis-Mortari, B. R. Blazar, J. S. Miller, W. Chen
Brd. 42D Use of a combination of 5-fluorouracil pathway genes to predict treatment
outcome of S-1 monotherapy in advanced gastric cancer. (Abstract #10554)
G. Kim, H. Jeung, S. Y. Rha, J. K. Roh, S. Noh, H. C. Chung
Brd. 42E Use of CD8 and Foxp3 immune infiltrates after neoadjuvant chemotherapy to
predict survival in HER2-overexpressing breast cancer patients. (Abstract
#10555)
F. Ghiringhelli, B. P. Coudert, L. Arnould, P. Fumoleau, S. Ladoire
Brd. 42F Efficient detection of EGFR alterations in lung adenocarcinomas. (Abstract
#10556)
M. G. Denis, S. Theoleyre, C. Chaplais, H. Gourdet, S. Caulet-Maugendre, H. Le
Ho, R. Corre, H. Lena, C. Sagan, J. Bennouna
Brd. 42G Comparison of different methods for detecting epidermal growth factor
receptor mutations in peripheral blood as a predictor of response to gefitinib.
(Abstract #10557)
J. Wu, H. Bai, G. Zhu, J. Xu, W. Jiang, L. Lin, C. Xue, L. Zhang
Brd. 42H Biomarkers of early operable primary breast cancer in elderly (> 70 years)
women (EPC) and their correlation with breast cancer-specific survival
(BCSS). (Abstract #10558)
B. M. Syed, A. R. Green, E. C. Paish, D. A. Morgan, I. O. Ellis, K. Cheung
Brd. 43A Clinical significance of 18 F-alpha-methyl tyrosine PET as a potential
surrogate marker of LAT1 expression for predicting prognosis of non-small
cell lung cancer. (Abstract #10559)
N. Oriuchi, K. Kaira, K. Shimizu, H. Tominaga, H. Hanaoka, Y. Arisaka, T. Higuchi,
T. Naoe, K. Endo
Brd. 43B Correlation of expression of circadian genes with liver metastasis and
outcomes in colorectal cancer. (Abstract #10560)
T. Oshima, C. Kunisaki, T. Sato, S. Fujii, N. Yamamoto, M. Shiozawa, M. Akaike,
Y. Rino, M. Masuda, T. Imada
Brd. 43C Epigenetic silencing of Dab-2 in head and neck cancer. (Abstract #10561)
C. Lo Nigro, L. Lattanzio, D. Vivenza, M. C. Merlano, T. Crook, G. Inman, M. Gasco
Brd. 43D The single-nucleotide polymorphism A>G rs397768 in APC gene as a new
biomarker of response to chemotherapy in advanced colorectal cancer.
(Abstract #10562)
J. Villa Guzman, R. Zarate, V. Boni, A. Gomez, J. De la Haba, E. Bandres,
J. Garcia-Foncillas, E. Aranda
108